| Mammalian mitophagy – from in vitro molecules to in vivo models CE Rodger, TG McWilliams, IG Ganley The FEBS journal 285 (7), 1185-1202, 2018 | 126 | 2018 |
| Cysteamine (Lynovex®), a novel mucoactive antimicrobial & antibiofilm agent for the treatment of cystic fibrosis C Charrier, C Rodger, J Robertson, A Kowalczuk, N Shand, D Fraser-Pitt, ... Orphanet journal of rare diseases 9, 1-11, 2014 | 71 | 2014 |
| HIF1α-dependent mitophagy facilitates cardiomyoblast differentiation JF Zhao, CE Rodger, GFG Allen, S Weidlich, IG Ganley Cell Stress 4 (5), 99, 2020 | 42 | 2020 |
| De novo VPS4A mutations cause multisystem disease with abnormal neurodevelopment C Rodger, E Flex, RJ Allison, A Sanchis-Juan, MA Hasenahuer, ... The American Journal of Human Genetics 107 (6), 1129-1148, 2020 | 40 | 2020 |
| Mechanistic basis of an epistatic interaction reducing age at onset in hereditary spastic paraplegia T Newton, R Allison, JR Edgar, JH Lumb, CE Rodger, PT Manna, T Rizo, ... Brain 141 (5), 1286-1299, 2018 | 30 | 2018 |
| ESCRT-III-associated proteins and spastin inhibit protrudin-dependent polarised membrane traffic JW Connell, RJ Allison, CE Rodger, G Pearson, E Zlamalova, E Reid Cellular and Molecular Life Sciences 77, 2641-2658, 2020 | 26 | 2020 |
| AP-4 regulates neuronal lysosome composition, function, and transport via regulating export of critical lysosome receptor proteins at the trans-Golgi network P Majumder, D Edmison, C Rodger, S Patel, E Reid, S Gowrishankar Molecular Biology of the Cell 33 (12), ar102, 2022 | 12 | 2022 |
| 74 Lynovex®, a novel mucolytic-antimicrobial agent for the treatment of cystic fibrosis C Charrier, C Rodger, N Shand, D Mercer, D O'Neil Journal of Cystic Fibrosis, S75, 2012 | 1 | 2012 |
| Atlastin-1 regulates endosomal tubulation and lysosomal proteolysis in human cortical neurons E Zlamalova, C Rodger, F Greco, J Kleniuk, AG Nadadur, Z Kadlecova, ... bioRxiv, 2024.02. 29.582512, 2024 | | 2024 |
| A metabolic checkpoint for mitophagy CE Rodger, GFG Allen, S Weidlich, T Macartney, I Ganley Biochimica et Biophysica Acta (BBA)-Bioenergetics, e25-e26, 2016 | | 2016 |
| Cysteamine (Lynovex®), a novel mucoactive antimicrobial & antibiofilm agent for the treatment of cystic fibrosis D O’Neil, D Mercer, D Fraser-Pitt, N Shand, A Kowalczuk, J Robertson, ... | | 2014 |
